We conducted a four-year (2003-2006) retrospective study of yeasts recovered in a hospital laboratory in the centre of Portugal to evaluate the epidemiology of yeast infections. Clinical isolates and data were gathered from 751 patients corresponding to 906 episodes of yeast infection. The isolates were fi rst identifi ed using classical and commercial methods, routinely employed at the hospital laboratory. We then re-identifi ed the same isolates using RFLP of the ITS 5.8S rRNA gene and sequence of the D1/D2 domain of the 26S rRNA gene. Candida parapsilosis isolates were re-identifi ed using the Ban I digestion of the SADH gene. C. albicans was the most frequently isolated of the yeasts found in the analysed specimens, with an overall incidence of 69.6% and then in deceasing order, C. glabrata , C. tropicalis , C. parapsilosis and C. krusei . C. parapsilosis was most frequently recovered from younger patients, decreasing with age, while C. glabrata occurrence increased with age. We found an increased number of cases of fungemia per 100,000 people per year, reaching a maximum of 4.4 during 2006.
infections involving Candida spp. can be considered as emerging infections. The origin of the yeast infection can either be endogenous or exogenous and several studies point to either possibility [ 1 -5 ] . Hedderwick and coworkers [ 6 ] carried out a 6-month surveillance of yeast colonization and infections in an adult intensive care unit, and found a low degree of cross-transmission for Candida albicans , but none for the other Candida species included in the investigation. Irrespective of this, the incidence of fungal infections has increased in the last three decades [ 7 -10 ] . This increase may be the result of the greater the number of patients with dysfunctional immune systems [ 11 ] due to iatrogenic factors. In particular, the yeasts of the genus Candida are considered as the most common fungal agents of nosocomial invasive fungal infections,
Introduction
Yeasts are ubiquitous in the environment and are also part of the normal fl ora of the human body. Many yeasts, particularly members of the genus Candida, are opportunistic pathogens causing infections in individuals with immune diseases or with a weakened immune system. Bloodstream
Materials and methods
This is a retrospective study including data from 2003 to 2006 concerning yeasts recovered as etiologic agents of human infections at the Centro Hospitalar de Coimbra (CHC). The hospital has a target population of 500,000 people (General Hospital and Maternity) and two million for the Paediatric Hospital.
Clinical data
Retrospectively, relevant clinical information of patients diagnosed with yeast infections obtained from the database of the Clinical Pathology Department of the CHC, were gathered and added to a data bank. The following risk factors/underlying diseases were considered; cystic fi brosis, immunodepression, cancer, diabetes, AIDS, catheter, postoperation status, pregnancy, antibiotic treatment, persistent fever (meaning persistent fever of unknown origin), solid organ transplant, admission in the reanimation unit, haemodialysis and burns. For every episode, the following data was recorded; age, gender, in-or outpatient status, yeast identifi cation, collection date and specimen from which the yeast was isolated.
Standard identifi cation procedure for yeasts isolated in the hospital laboratory
The methodology used in the microbiology laboratory of the Clinical Pathology Department of the CHC starts with a direct microscopic examination of a smear of the specimen. This is followed by inoculating a portion of the specimen onto Sabouraud medium or blood culture bottle (BACTEC 9240 System with Aerobic Plus or F blood culture bottles (Becton Dickinson, The Netherlands). When the presence of yeast colonies was suspected, a rapid identifi cation procedure was performed using the Bichro Latex albicans Fumouze (Fumouze Diagnostics, France), with a positive result indicating the identifi cation of C. albicans . Alternatively, if the test result was negative, the Api ® ID32C (bioMérieux, Portugal) was used in identifying the isolate.
Re-identifi cation of yeasts by molecular biology methods
The yeast isolates were re-identifi ed using RFLP of the 5.8S rRNA gene and of the adjacent ITS1 and ITS2, and by sequencing the D1/D2 contiguous fragments of the 26S rDNA. Total genomic DNA was extracted using the isopropanol method and specifi c gene amplifi cation was obtained using the primers in Table 1 . The identifi cation by RFLP of the 5.8S and ITS1 and ITS2 region of the 18S rDNA was carried out as described previously [19] [20] [21] . Reference strains of C. dubliniensis and C. lusitaniae were obtained and, using the methodology described above, we determined the restriction patterns of these species (results not shown). The sequencing of the D1/D2 contiguous fragments of the 26S rDNA was performed according to Kurtzman and Robnett [ 22 ] , and assumed as the reference method. The sequences obtained were used to identify the yeasts by BLAST-search (GenBank; www.ncbi.nlm.nih.gov ).
Using , the re-identifi cation of the clinical isolates of Candida 
Statistics
Descriptive statistics was used to summarize the data. Risk factors signifi cantly associated with bloodstream infections in the univariate analysis that occurred in Ͼ5% of patients were evaluated in a stepwise logistic regression model.
Results

Demographic characteristics and risk factors
The total number of yeast infections diagnosed during the period in study was 906, although this number does not correspond to the number of patients since 155 suffered from repeat episodes. The total number of patients with at least one yeast infection was 751. The distribution of patients in age groups ( Table 2 ) showed that the number of cases increased with age. During the 4-year period, there was a considerable increase in the number of cases diagnosed at the hospital laboratory each year. As for the gender, 52.3% of episodes occurred in men, and 47.7% in women ( Table 2 ) . This study aimed at analyzing the spectrum of yeast infections and all the yeast isolates to which an aetiological role was attributed, independently of the place/tissue of infections. Consequently, they were recovered from different biological products ( Table 2 ). Respiratory and urinary tract specimens were the most frequent source of yeasts. The number of blood isolates, corresponding to bloodstream infections (BSI) was 36, and the number of catheters from which yeasts were recovered was 60.
The clinical data of the patients from whom the isolates were obtained, either as in-or outpatients, was analyzed according to the underlying diseases and/or predisposing conditions, with the purpose of identifying the most important risk factors. A high number of episodes (248) did not have any associated risk factors. The highest numbers of episodes were associated with prolonged antibiotic treatment and persistent fever ( Table 2 ) .
Re-identifi cation of the clinical isolates by molecular biology
Our results showed that the methodology used by the microbiology laboratory of the Clinical Pathology Department of the CHC was very accurate and reliable, since only two isolates were misidentifi ed when results were compared to those with the two different molecular techniques. One isolate, obtained from a urine sample was fi rst identifi ed with the hospital routine procedures as C. guilliermondii and re-identifi ed as C. albicans using the RFLP method. Surprisingly, when the D1/D2 domain of the 26S rDNA was sequenced, this same isolate was re-identifi ed as C. tropicalis . Since we assumed this last procedure as the
Spectrum of agents
The fi ve species most often recovered were, in decreasing order, C. albicans , C. glabrata , C. tropicalis , C. parapsilosis and C. krusei ( Table 3 ) . C. albicans accounted for 69.6% of the total number of yeast infections while non-C. albicans Candida species accounted for 28.3% of the yeast infections ( Table 3 ) . A total of 8 isolates of Saccharomyces cerevisiae were obtained. In regard to Cryptococcus neoformans , besides the systemic isolates, two were obtained from skin lesions ( Table 3 ) . From the analysis of the incidence of non-C. albicans Candida species in different age groups ( Fig. 2 ) , we conclude that C. parapsilosis is the predominant species in patients up to 16 years, whereas C. glabrata is more common in patients older than 16 years of age. Starting at the age group from 16 to 40 years, the relative incidence of C. glabrata increased progressively, whereas C. parapsilosis followed the opposite tendency.
Blood stream infections (BSI)
The number of blood cultures positive for yeasts obtained during the period considered in this study was 89. . Of the 50 isolates identifi ed as C. parapsilosis , to which clinical pathologists originally attributed aetiological signifi cance, fi ve were re-identifi ed as C. metapsilosis and six as C. orthopsilosis . The restriction patterns of some of the re-identifi ed isolates are depicted in Fig. 1 , along with the restriction pattern of C. parapsilosis . In the group of yeasts re-identifi ed as C. orthopsilosis , one was isolated from peritoneal fl uid of a 25-day-old infant with an intestinal perforation admitted in the intensive care unit (ICU). One month later, C. orthopsilosis was again recovered from the blood of the same patient. At the time of blood collection and when admitted to the ICU, the patient was being medicated with antibiotics. A third isolate of the same species was obtained from a catheter in the same boy. Among the isolates re-identifi ed as C. metapsilosis , a particular isolate was more thoroughly investigated since it had been recovered from peritoneal fl uid of a liver transplant patient, who received three liver transplants. The fi rst isolate was recovered from a drainage catheter after the third transplant. It was identifi ed by the microbiology laboratory as C. parapsilosis . The same yeast was also obtained from peritoneal fl uid and from a urinary catheter. A histopathological analysis of a liver biopsy, also from that period, revealed yeast cells. Fig. 1 Re-identifi cation of clinical isolates of Candida parapsilosis by RFLP of the SADH gene by the enzyme BanI. The resulting fragments were separated by electrophoresis in a 1% agarose gel. Legend: Lane 11 -C. metapsilosis ; Lanes 4, 8, 14 -C. orthopsilosis ; Lanes 2, 3, 5, 6, 7, 9, 10, 12, 13, 15, 16, 17 -C. from 36 cases. Of the total episodes of candidemia considered, about 95% were detected in in-patients. Candida albicans was the most frequent yeast species (61.1%) followed by C. parapsilosis (22.2%), Cryptococcus neoformans (8.3%). One of the isolates fi rst identifi ed as C. parapsilosis , was re-identifi ed as C. orthopsilosis . It is noteworthy that there was an absence of C. tropicalis and C. krusei , which are frequently found as pathogens in other sites such as the respiratory and urinary tracts. The results showed four episodes of C. krusei associated with catheters, but none in blood culture. A statistical study was performed in order to assess the probability of a patient developing a blood stream yeast infection. The results showed that the only variables with statistic impact was the presence of HIV (ORϭ2.962; P ϭ0.035) or haemodialysis (ORϭ12.411; P ϭ0.050). This last parameter shows a hypothetically led to the omission of important risk factors. This limitation has been described in other epidemiological studies based in hospital laboratories and the clinical data associated with it [ 35 ] . One of the most serious yeast infections is that of the bloodstream, which is associated with a high mortality [ 10 ] . In addition to the increased frequency of this type of infection, there is also a tendency for the emergence of new pathogenic species. A study recently published in the Portuguese population showed that the incidence of fungemia is 2.7 per 1,000 hospital admissions with a mortality rate of 39.3% [ 12 ] .
The diagnosis of fungemia is sometimes hindered by the methods used to establish it. Blood culture methods may often yield false negative results at an early stage of infection [ 36 ] . According to Pfaller and Diekema [ 10 ] , the frequency with which blood culture tests are requested and the type of culture employed can affect the fungemia incidence rates in epidemiological studies based on laboratory results. A study concerning the effi ciency of the BACTEC 9240, the blood culture bottle used in the investigation, showed that it only spiked with 100 CFU/ml of different yeasts. Therefore, about 10% of the aerobic culture bottles gave false negative results after a 21-day incubation. Furthermore, the percentage of false negatives increased when the incubation time was reduced to 5 days [ 37 ] . Considering that in many cases of bloodstream infection the concentration of yeast cells can be less than 10 CFU/ml [ 38 ] , we can infer that the clinical practice, using a 5-day incubation period, may be expected to yield an even larger percentage of false negative results. The number of candidemia episodes obtained during this study is close to the incidence found in other European countries like Norway (2 and 3 per 100,000 inhabitants) and Spain (4.9 per 100,000 inhabitants). However, the incidence of candidemia in this investigation is considerably lower than that found in North American studies (between 6 and 24 cases per 100,000 inhabitants, per year) [ 10 ] . A study recently published showed that in Scotland the incidence of candidemia is 4.8 cases per 100,000 population per year [ 35 ] . Nevertheless, we believe that the number of laboratory diagnosed bloodstream infections is certainly below the real incidence. In many cases in which there was a strong clinical suspicion of a fungal infection, antifungal medication was administered with a positive outcome even when the blood culture test turned negative. A reliable, highly effi cient method for detecting yeast blood infections is required.
Although this study included a wide range of clinical isolates, from skin to systemic candidiosis, we believe that at the clinical setting level, it is more important to recognize the probability of a patient to develop a systemic yeast infection, than a localized yeast infection. Others have pointed that this is especially true if certain risk factors are higher odds ratio when it is associated with patients who are over 65 years (ORϭ16.920; P ϭ0.048). In addition, patients in which the clinician described persistent fevers of unknown origin have higher probability of a BSI (ORϭ4.05; P ϭ0.001).
Discussion
The main goal of this study was to understand the incidence of yeast infections in a population in the centre of Portugal and to assess the accuracy of the identifi cation procedures used. It was also our aim to identify groups of patients at higher risk of acquiring a BSI.
The main risk factors contributing to yeast infections and their classifi cation in order of importance have been the subject of several studies [ 10 , 24 ] . Suggestions have been made of the usefulness of assessing the need for early therapy or even prophylaxis against fungal infections, now that the most important risk factors are known [ 10 ] such as catheterized patients [ 25 ] , those receiving prolonged antibiotic treatment [ 26 ], pregnancy [ 27 ] , patients with uncontrolled diabetes [ 28 ] , solid organ transplant recipients [ 29 ] , patients with AIDS [ 30 ] and cancer patients undergoing cytotoxic chemotherapy [ 29 ] . In the population here studied, the majority of yeast infections occurred in patients with all of these risk factors.
Age is also a critical factor and was considered in our study. As expected, the age group where the most yeast infections were diagnosed was in patients over 65 years. The latter tend to present signs of immunosenescence, a gradual reduction of the effectiveness of the immune system due to the natural ageing process [ 31 ] . Additionally, the ageing of the mucosa and the skin weakens nonspecifi c defences against invading microorganisms [ 32 ] . Also, the patients in this age group have increased probability of suffering from diseases which are risk factors for yeast infections, such as diabetes, renal insuffi ciency (haemodialysis) and cancer (chemotherapy) [ 26, 29, 33, 34 ] . Accordingly, the data we obtained showed that patients older than 65 years under haemodialysis had the highest risk of developing a BSI.
The observation that a high number of episodes was not associated with a risk factor clearly indicates that either the clinical data of the clinical pathology database are not complete and/or there are clinical features that clinicians do not identify as being related to fungal infections. However, it is important to note that the data was collected from the database of the Clinical Pathology Department of the CHC and not from the complete clinical fi le of the patients. It is likely that the transfer of clinical information between the assisting physician and the clinical pathologist might be incomplete. The retrospective nature of the study, coupled to the exiguous data transfer to the clinical pathologist, C. dubliniensis is usually associated with HIV-positive patients although some cases have been reported in other patient populations [ 49 ] . C. dubliniensis may be easily misidentifi ed as C. albicans due to their close phenotypic resemblance [ 50 ] . The re-identifi cation of C. albicans isolates by sequencing of the D1/D2 domains of the 26S rRNA gene confi rmed that in the period considered in this study no C. dubliniensis strains were isolated. In a one-year prevalence study in a Dutch hospital, 0.8% of the germ tube positive yeasts were C. dubliniensis [ 49 ] . An American study mentioned an incidence of 0.9% for this species [ 51 ] , with most isolates recovered from oropharyngeal and fecal samples. Given these previous reports of low incidence, and considering that our investigation did not include oropharyngeal specimens and only includes a total of 38 C. albicans isolated from fecal specimens, this fi nding would be expected. Nevertheless, a report using a peptide nucleic acid fl uorescent in situ hybridization analysis showed incidences of 7% in blood specimens [ 52 ] .
The new yeast species belonging to the C. parapsilosis group, C. metapsilosis and C. orthopsilosis , were described during 2005 [ 23 ] . C. metapsilosis , was previously classifi ed as C. parapsilosis group III and was considered a nonpathogen [ 53 , 55 ] . The species was thought to be best adapted to a non-mammalian environment, as opposed to C. parapsilosis and C. orthopsilosis [ 23 ] . Additionally, the same authors considered the possibility of the latter species to be the evolutional ancestor of C. parapsilosis and C. orthopsilosis . An in vitro study compared the virulence of the three species in human reconstituted epidermis and oral epithelium, indicating that C. metapsilosis is less virulent than C. parapsilosis and C. orthopsilosis [ 54 ] . Nevertheless, Kocsubé and co-workers reported the isolation of a C. metapsilosis from a BSI [ 55 ] . And, recently it was reported in Spain that the prevalence of C. metapsilosis is 1.7% and 1.4% for C. orthopsilosis , as agents of candidemia [ 56 ]. Here we described one case of systemic infection/ colonization by C. metapsilosis from a very critical patient. During the 4-year period of this study, the number of BSI due to C. orthopsilosis was one.
Final remarks
This study intended to analyze yeasts isolated from every possible biological specimen. In the literature, we could not fi nd studies with a similar objective and the majority of available studies focus on BSI. The presence and isolation of yeasts from normally sterile sites, such as blood and cerebrospinal fl uid, is suffi cient to make a diagnosis of infection, while yeasts recovered from wounds, urine, sputum or faeces have a reserved etiological signifi cance as they could be commensals and/or yeast contaminants. The diagnosis of diseases caused by yeasts has to be based present, for example if gastrointestinal pathologies are present [ 12, 35 ] .
A conclusion drawn from this study is that the combination of methods used in the microbiology laboratory of the clinical pathology service of CHC are excellent since only two yeast isolates were re-identifi ed by molecular biology as different species. We did not consider for this calculation the re-identifi cation of the isolates of C. parapsilosis , since C. metapsilosis and C. orthopsilosis are new species that did not yet exist in the databases of the clinical routine identifi cation methods. The combination of several methods certainly contributes to the quality and effi cacy of the identifi cation procedure routinely used at the hospital laboratory.
In recent years there has been a growing interest in using and developing new identifi cation methods based on molecular biology, like real-time PCR [ 39 ], sequencing and/or RFLP of different regions of the genome [ 18 ,21, 40, 41 ] . These techniques take advantage of regions of the genome, which, in addition to being conserved in all yeast species, have a great interspecies variability. These methods provide more reliable results in a shorter period of time. However, the cost of the equipment and need for highly trained staff may be disadvantages to their use.
A characterization of yeast infections requires the analysis of the isolated species. Although most epidemiological studies in the literature concern BSI, C. albicans would be expected to be the most frequently isolated yeast. In spite of that, it is noteworthy that we found a great variety of non-C. albicans Candida species. In the literature, there are several reports indicating the tendency for diversifi cation of species of yeast pathogenic to humans [ 10, 42 ] . This can be due to the increased number of individuals with greater susceptibility to this kind of infectious agents, as well as to the selection of several species due to differences in their intrinsic susceptibilities to some of the most frequently employed antifungals [ 10, 43 ] . The distribution of infections within the age group of this study was similar to those obtained in an investigation in the USA concerning systemic infections [ 10 ] . Studies conducted in neonatal ICUs concluded that neonates became colonized by C. parapsilosis acquired from the ICU setting and not from their mothers [44] [45] [46] . This yeast species was also the most commonly isolated from the hands of healthcare workers, due to the ability of higher persistence on the hands [ 47 ]. However, no link was found between this and patient acquisition of the infection/colonization [ 6 ] .
Saccharomyces cerevisiae is an uncommon pathogen. Disease caused by this 'friendly' yeast is associated with severe immunosuppressed patients [ 48 ] . During the fouryear period of this study, none of the eight isolates were recovered from immunocompetent patients. In the majority of circumstances the patients were very debilitated or immunodepressed.
on clinical data (fever, skin lesions) and epidemiologic indicators (risk factors), rather than just on the isolation of the fungus [ 57 ]. However, even if a yeast isolate is not considered as an agent of infection at one site, its presence may be the basis for the development of a secondary pathology. Colonization is a factor of increased risk for many fungal infections. Because of their opportunistic nature, they may continue as colonizers until the host enters a clinical state that is favourable for proliferation and invasion of tissue [ 58, 59 ] .
